Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Sabag Mark See "Remarks" Option exercise +44,710 $34.90 $1.6M 125,470
2026-11-12 Sabag Mark See "Remarks" Sale −44,710 $44.14 $2.0M 80,760
2026-11-12 Sabag Mark See "Remarks" Option exercise · Stock Options (right to buy) −44,710 0
2026-11-11 Daniell Richard EVP, Europe Commercial Option exercise +20,003 $34.70 $694K 75,758
2026-11-11 Daniell Richard EVP, Europe Commercial Sale −20,003 $42.80 $856K 55,755
2026-11-11 Daniell Richard EVP, Europe Commercial Option exercise · Stock Options (right to buy) −20,003 0
2026-11-10 Francis Richard D President and CEO Sale 10b5-1 −250,000 $42.24 $10.6M 927,529
2026-11-10 Bergwerk Dov Interim Chief Legal Officer Grant or award · Restricted Share Units +9,433 9,433
2026-11-10 BRAILER DAVID J Director Grant or award · Restricted Share Units +3,326 3,326
2026-11-09 Daniell Richard EVP, Europe Commercial Option exercise +25,000 $34.70 $868K 80,755
2026-11-09 Daniell Richard EVP, Europe Commercial Sale −25,000 $42.91 $1.1M 55,755
2026-11-09 Daniell Richard EVP, Europe Commercial Option exercise · Stock Options (right to buy) −25,000 20,003
2026-11-09 Weiss Amir Chief Accounting Officer Option exercise +7,755 $34.70 $269K 20,826
2026-11-09 Weiss Amir Chief Accounting Officer Sale −662 $43.15 $29K 20,164
2026-11-09 Weiss Amir Chief Accounting Officer Sale −7,093 $43.03 $305K 13,071
2026-11-09 Weiss Amir Chief Accounting Officer Sale −9,534 $43.03 $410K 3,537
2026-11-09 Weiss Amir Chief Accounting Officer Option exercise · Stock Options (right to buy) −7,755 0
2026-11-05 Sabag Mark See "Remarks" Option exercise +46,000 $34.90 $1.6M 126,760
2026-11-05 Sabag Mark See "Remarks" Sale −46,000 $41.93 $1.9M 80,760
2026-11-05 Sabag Mark See "Remarks" Option exercise · Stock Options (right to buy) −46,000 44,710

Page 1 of 76 · 1,517 trades